Evaluation of the Pre-Posterior Distribution of Optimized Sampling Times for the Design of Pharmacokinetic Studies
暂无分享,去创建一个
[1] Andrew C. Hooker,et al. Robust Population Pharmacokinetic Experiment Design , 2005, Journal of Pharmacokinetics and Pharmacodynamics.
[2] Malcolm Rowland,et al. Optimal Design for Multivariate Response Pharmacokinetic Models , 2006, Journal of Pharmacokinetics and Pharmacodynamics.
[3] W. Näther. Optimum experimental designs , 1994 .
[4] Stephen B. Duffull,et al. Prospective Evaluation of a D-Optimal Designed Population Pharmacokinetic Study , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[5] Stephen Duffull,et al. Some Considerations on the Design of Population Pharmacokinetic Studies , 2005, Journal of Pharmacokinetics and Pharmacodynamics.
[6] L Pronzato,et al. Optimal experiment design for nonlinear models subject to large prior uncertainties. , 1987, The American journal of physiology.
[7] L Aarons,et al. Design of population pharmacokinetic experiments using prior information. , 2007, Xenobiotica; the fate of foreign compounds in biological systems.
[8] Leon Aarons,et al. Optimum blood sampling time windows for parameter estimation in population pharmacokinetic experiments , 2006, Statistics in medicine.
[9] J. Eccleston,et al. Compound Optimal Design Criteria for Nonlinear Models , 2008, Journal of biopharmaceutical statistics.
[10] D Z D'Argenio,et al. Incorporating prior parameter uncertainty in the design of sampling schedules for pharmacokinetic parameter estimation experiments. , 1990, Mathematical biosciences.
[11] Jean-Marie Rocchisani,et al. Comparison of ED, EID, and API Criteria for the Robust Optimization of Sampling Times in Pharmacokinetics , 1997, Journal of Pharmacokinetics and Biopharmaceutics.
[12] Paolo Vicini,et al. Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experiments , 2005, The AAPS Journal.
[13] Alain Mallet,et al. Optimal design in random-effects regression models , 1997 .
[14] Christian P. Robert,et al. Monte Carlo Statistical Methods , 2005, Springer Texts in Statistics.
[15] France Mentré,et al. Optimal Design of a Population Pharmacodynamic Experiment for Ivabradine , 2004, Pharmaceutical Research.
[16] Gordon Graham,et al. Optimal Design for Multiresponse Pharmacokinetic–Pharmacodynamic Models – Dealing with Unbalanced Designs , 2007, Journal of Pharmacokinetics and Pharmacodynamics.
[17] Stephen B. Duffull,et al. Optimal Design for Model Discrimination and Parameter Estimation for Itraconazole Population Pharmacokinetics in Cystic Fibrosis Patients , 2005, Journal of Pharmacokinetics and Pharmacodynamics.
[18] Leon Aarons,et al. Optimal Blood Sampling Time Windows for Parameter Estimation Using a Population Approach: Design of a Phase II Clinical Trial , 2005, Journal of Pharmacokinetics and Pharmacodynamics.
[19] France Mentré,et al. Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population Pharmacokinetics , 2003, Journal of biopharmaceutical statistics.
[20] David Z. D'Argenio,et al. Optimal sampling times for pharmacokinetic experiments , 1981, Journal of Pharmacokinetics and Biopharmaceutics.
[21] K. Chaloner,et al. Bayesian Experimental Design: A Review , 1995 .